![](https://tracker.live.rns-distribution.com/track.live-rns/5220084_d9353a075fe0b610698e373da828b7e4.png)
11 June 2024
EQTEC plc
("EQTEC", the "Company" or the "Group")
Equity placement update and total voting rights
EQTEC plc (AIM: EQT), a global technology innovator powering distributed, decarbonised, new energy infrastructure through its waste-to-value solutions for hydrogen, biofuels, and energy generation, announces that further to its announcements of 28 May 2024 and 31 May 2024, receipt of the remaining £502,425 in relation to the Placing in accordance with the previously indicated timetable, resulting in the issuance of 35,887,491 new Shares to the relevant subscribers (the "Placing Shares").
The new Shares detailed above are being issued utilising the Company's existing share authorities and will rank pari passu in all respects with the Company's existing Shares.
Application is being made to the London Stock Exchange for admission of the Placing Shares ("Admission"), being in aggregate 35,887,491 new Shares and it is expected that Admission will become effective and that dealings in the new Shares on AIM will commence at 8.00 a.m. on or around 14 June 2024.
Following Admission, there will be 257,610,911 Shares in issue. The Company holds no Shares in Treasury. This number may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.
Unless otherwise defined herein, all defined terms used in this announcement shall have the meanings ascribed to them in the Company's announcements of 28 May 2024.
ENQUIRIES
EQTEC plc David Palumbo / Jeffrey Vander Linden
| +44 20 3883 7009 |
Strand Hanson - Nomad & Financial Adviser James Harris / Richard Johnson
| +44 20 7409 3494 |
Global Investment Strategy UK Ltd - Broker Samantha Esqulant
| +44 20 7048 9045 |
Fortified Securities - Broker Guy Wheatley
| +44 20 3411 7773 |
About EQTEC plc
As one of the world's most experienced thermochemical conversion technology and engineering companies, EQTEC delivers waste management and new energy solutions through best-in-class innovation and infrastructure engineering and value-added services to owner-operators. EQTEC is one of only a few technology providers directly addressing the challenge of replacing fossil fuels for reliable, baseload energy. EQTEC's proven, proprietary and patented technology is at the centre of clean energy projects, sourcing local waste, championing local businesses, creating local jobs and supporting the transition to localised, decentralised and resilient energy systems.
EQTEC designs, specifies and delivers clean, syngas production solutions in the USA, EU and UK, with highly efficient equipment that is modular and scalable from 1MW to 30MW. EQTEC's versatile solutions process 60 varieties of feedstock, including forestry waste, agricultural waste, industrial waste and municipal waste, all with no hazardous or toxic emissions. EQTEC's solutions produce a pure, high-quality synthesis gas ("syngas") that can be used for the widest range of applications, including the generation of electricity and heat, production of renewable natural gas (through methanation) or biofuels (through Fischer-Tropsch, gas-to-liquid processing) and reforming of hydrogen.
EQTEC's technology integration capabilities enable the Group to lead collaborative ecosystems of qualified partners and to build sustainable waste reduction and green energy infrastructure around the world.
The Company is quoted on AIM (ticker: EQT) and the London Stock Exchange has awarded EQTEC the Green Economy Mark, which recognises listed companies with 50% or more of revenues from environmental/green solutions.
Further information on the Company can be found at www.eqtec.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.